MFDS
- Marketing authorisation holder: ZEVRA DENMARK
- Status: likely_approved
🇰🇷 Miplyffa in South Korea
Miplyffa (ARIMOCLOMOL) regulatory status in South Korea.
Marketing authorisation
Miplyffa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Miplyffa approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Miplyffa in South Korea?
ZEVRA DENMARK holds the South Korean marketing authorisation.